Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

Clinical calculator summary

CAPRA Score

The CAPRA score predicts biochemical recurrence-free survival after radical prostatectomy.

Evidence-based context for fast calculator use

Purpose:
CAPRA score predicts prostate cancer recurrence after radical prostatectomy using PSA, Gleason, and stage to stratify pre-operative risk.
Population:
patients undergoing prostate cancer diagnostic, pathologic, recurrence, or molecular-risk assessment
Factors:
Age, PSA, Gleason Pattern, Clinical T-Stage, % Positive Biopsy Cores
Reference:
Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938-1942.
HomeCAPRA Score
Pin your most used calculators here by clicking the star in the dropdown.

CAPRA Score

Clinical Context & Background

The CAPRA score predicts biochemical recurrence-free survival after radical prostatectomy. It is calculated using age, PSA, Gleason score, clinical stage, and percent of biopsy cores positive for cancer. A score of 0-2 indicates low risk, while 6-10 indicates high risk.
Primary Source EvidenceCooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938-1942.
Formula Logic
Sum of points from PSA, Gleason, Stage, %Positive Cores, and Age.

Reference Data

Risk GroupCAPRA Score5-Year RFS
Low Risk0 - 2~91%
Intermediate Risk3 - 5~74%
High Risk6 - 10~56%

Clinical Workflow

Use, Interpret, And Continue The Patient Pathway

Expand for workflow guidance, limitations, examples, and related next steps.

When To Use

  • Use CAPRA Score when cAPRA score predicts prostate cancer recurrence after radical prostatectomy using PSA, Gleason, and stage to stratify pre-operative risk.
  • Confirm that the patient, diagnosis, disease phase, and available inputs match the cited model before calculation.

How To Interpret

  • Interpret the displayed result using the calculator-specific formula and reference table, spanning Low Risk through High Risk.
  • A boundary result should prompt input verification and clinical review rather than false precision.

What To Do Next

  • Confirm biopsy versus prostatectomy setting, PSA timing, grade group, clinical/pathologic stage, imaging, life expectancy, and treatment history.
  • Document the inputs, result, timing, and clinical context so the assessment can be reproduced.

Limitations

  • Diagnostic, post-prostatectomy, genomic, and recurrence tools must be used only at their intended decision point.
  • The result supports clinician judgment and does not independently determine treatment.

Validated Population

patients undergoing prostate cancer diagnostic, pathologic, recurrence, or molecular-risk assessment

How to apply this result

For a representative case, verify Age, PSA, Gleason Pattern, calculate the result, and confirm that its classification matches the highlighted reference band before continuing the disease-specific pathway.

Prostate Cancer hubContinue to related calculators and clinical workflow resources.

Share This Calculator

Share:

Related Tools

D'Amico Risk ClassificationEpstein Criteria (Insignificant Cancer)PI-RADS™ v2.1 (Prostate MRI)

Frequently Asked Questions

When should CAPRA Score be used?

Use it for patients undergoing prostate cancer diagnostic, pathologic, recurrence, or molecular-risk assessment when all required inputs and the intended clinical setting are confirmed.

Can CAPRA Score determine treatment by itself?

No. Interpret the result with the cited evidence, complete clinical assessment, current guidelines, and patient-specific goals.

Evidence-based oncology decision support. Verify with clinical guidelines.